Cell technologies in retinitis pigmentosa treatment
The growing crucial problem in practical ophthalmology relates to growth of hereditary degenerative diseases of the retina, in particular retinitis, causing progressive loss of visual functions. According to international estimates, the incidence rate of hereditary dystrophy contains 1 case per 3000...
Saved in:
Main Authors: | Zeinet Akhmedyanova (Author), Manshuk Yeltokova (Author), Zhanna Bayanbayeva (Author), Assel Khassenova (Author) |
---|---|
Format: | Book |
Published: |
National Scientific Medical Center,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of autologous mesenchymal stem cells in complications of diabetes mellitus, in particular diabetic retinopathy: inputs and insights
by: Manshuk Yeltokova, et al.
Published: (2022) -
Psychological disorders in patients with retinitis pigmentosa in iran.
by: Farhad Adhami-Moghadam, et al.
Published: (2014) -
Antioxidant and Biological Properties of Mesenchymal Cells Used for Therapy in Retinitis Pigmentosa
by: Paolo Giuseppe Limoli, et al.
Published: (2020) -
Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development
by: Kevin Y. Wu, et al.
Published: (2023) -
Molecular Mechanisms Related to Oxidative Stress in Retinitis Pigmentosa
by: Carla Enrica Gallenga, et al.
Published: (2021)